Skip to main content

1620 INVESTMENT ADVISORS, INC.

Position in NBIX — Neurocrine Biosciences Inc

CIK 1907281 PLYMOUTH, MA

Position in NBIX

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$168,034
+$64,355 QoQ
Shares Held
997
+26.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#609
of 768 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

1620 INVESTMENT ADVISORS, INC. holds $895,573 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (18.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
997 $168,034

All Filings in NBIX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $168,034 997
2026-03-31 $103,679 787
2025-12-31 $129,348 912
2025-09-30 $127,886 911
2025-06-30 $116,137 924
2025-03-31 $102,526 927
2024-12-31 $127,354 933
2024-09-30 $99,895 867
2024-06-30 $117,983 857